Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2016 3
2017 4
2018 4
2019 5
2020 3
2021 5
2022 8
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

27 results

Results by year

Filters applied: . Clear all
Page 1
Experimental in vitro, ex vivo and in vivo models in prostate cancer research.
Sailer V, von Amsberg G, Duensing S, Kirfel J, Lieb V, Metzger E, Offermann A, Pantel K, Schuele R, Taubert H, Wach S, Perner S, Werner S, Aigner A. Sailer V, et al. Among authors: lieb v. Nat Rev Urol. 2023 Mar;20(3):158-178. doi: 10.1038/s41585-022-00677-z. Epub 2022 Nov 30. Nat Rev Urol. 2023. PMID: 36451039 Review.
Active surveillance inclusion criteria under scrutiny in magnetic resonance imaging-guided prostate biopsy: a multicenter cohort study.
Kornienko K, Siegel F, Borkowetz A, Hoffmann MA, Drerup M, Lieb V, Bruendl J, Höfner T, Cash H, von Hardenberg J, Westhoff N; GESRU Academics Prostate Cancer Group. Kornienko K, et al. Among authors: lieb v. Prostate Cancer Prostatic Dis. 2022 Mar;25(1):109-116. doi: 10.1038/s41391-021-00478-2. Epub 2021 Dec 17. Prostate Cancer Prostatic Dis. 2022. PMID: 34916584 Free PMC article.
Efficacy of cabazitaxel in fourth or later line of therapy in metastatic castration-resistant prostate cancer: Multi-institutional real-world experience in Germany.
Wenzel M, Borkowetz A, Lieb V, Hoffmann MA, Borgmann H, Höfner T, Dotzauer R, Neuberger M, Worst TS, von Hardenberg J, Linxweiler J, Klümper N. Wenzel M, et al. Among authors: lieb v. Urol Oncol. 2022 Dec;40(12):538.e7-538.e14. doi: 10.1016/j.urolonc.2022.09.011. Epub 2022 Oct 14. Urol Oncol. 2022. PMID: 36244915
Combined miR-486 and GP88 (Progranulin) Serum Levels Are Suggested as Supportive Biomarkers for Therapy Decision in Elderly Prostate Cancer Patients.
Fichte A, Neumann A, Weigelt K, Guzman J, Jansen T, Keinert J, Serrero G, Yue B, Stöhr R, Greither T, Hartmann A, Wullich B, Taubert H, Wach S, Lieb V. Fichte A, et al. Among authors: lieb v. Life (Basel). 2022 May 13;12(5):732. doi: 10.3390/life12050732. Life (Basel). 2022. PMID: 35629399 Free PMC article.
27 results